Kenanova VE - Search Results

1

Numerical comparison of iodine-based and indium-based antibody biodistributions.

Williams LE, Wu AM, Kenanova VE, Olafsen T, Yazaki PJ. Williams LE, et al. Among authors: kenanova ve. Cancer Biother Radiopharm. 2014 Apr;29(3):91-8. doi: 10.1089/cbr.2013.1564. Epub 2014 Jan 20. Cancer Biother Radiopharm. 2014. PMID: 24443889

2

Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging.

Olafsen T, Kenanova VE, Sundaresan G, Anderson AL, Crow D, Yazaki PJ, Li L, Press MF, Gambhir SS, Williams LE, Wong JY, Raubitschek AA, Shively JE, Wu AM. Olafsen T, et al. Among authors: kenanova ve. Cancer Res. 2005 Jul 1;65(13):5907-16. doi: 10.1158/0008-5472.CAN-04-4472. Cancer Res. 2005. PMID: 15994969 Free PMC article.

3

Tailoring the pharmacokinetics and positron emission tomography imaging properties of anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments.

Kenanova V, Olafsen T, Crow DM, Sundaresan G, Subbarayan M, Carter NH, Ikle DN, Yazaki PJ, Chatziioannou AF, Gambhir SS, Williams LE, Shively JE, Colcher D, Raubitschek AA, Wu AM. Kenanova V, et al. Cancer Res. 2005 Jan 15;65(2):622-31. Cancer Res. 2005. PMID: 15695407 Free PMC article.

4

Radioiodinated versus radiometal-labeled anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments: optimal pharmacokinetics for therapy.

Kenanova V, Olafsen T, Williams LE, Ruel NH, Longmate J, Yazaki PJ, Shively JE, Colcher D, Raubitschek AA, Wu AM. Kenanova V, et al. Cancer Res. 2007 Jan 15;67(2):718-26. doi: 10.1158/0008-5472.CAN-06-0454. Cancer Res. 2007. PMID: 17234783

5

Tuning the serum persistence of human serum albumin domain III:diabody fusion proteins.

Kenanova VE, Olafsen T, Salazar FB, Williams LE, Knowles S, Wu AM. Kenanova VE, et al. Protein Eng Des Sel. 2010 Oct;23(10):789-98. doi: 10.1093/protein/gzq054. Epub 2010 Aug 28. Protein Eng Des Sel. 2010. PMID: 20802234 Free PMC article.

6

A two-tiered physiologically based model for dually labeled single-chain Fv-Fc antibody fragments.

Ferl GZ, Kenanova V, Wu AM, DiStefano JJ 3rd. Ferl GZ, et al. Mol Cancer Ther. 2006 Jun;5(6):1550-8. doi: 10.1158/1535-7163.MCT-06-0072. Mol Cancer Ther. 2006. PMID: 16818514

7

Anti-CA19-9 diabody as a PET imaging probe for pancreas cancer.

Girgis MD, Kenanova V, Olafsen T, McCabe KE, Wu AM, Tomlinson JS. Girgis MD, et al. J Surg Res. 2011 Oct;170(2):169-78. doi: 10.1016/j.jss.2011.03.065. Epub 2011 Apr 20. J Surg Res. 2011. PMID: 21601881

8

Recombinant anti-CD20 antibody fragments for small-animal PET imaging of B-cell lymphomas.

Olafsen T, Betting D, Kenanova VE, Salazar FB, Clarke P, Said J, Raubitschek AA, Timmerman JM, Wu AM. Olafsen T, et al. Among authors: kenanova ve. J Nucl Med. 2009 Sep;50(9):1500-8. doi: 10.2967/jnumed.108.060426. Epub 2009 Aug 18. J Nucl Med. 2009. PMID: 19690034 Free PMC article.

9

Anti-carcinoembryonic antigen single-chain variable fragment antibody variants bind mouse and human neonatal Fc receptor with different affinities that reveal distinct cross-species differences in serum half-life.

Andersen JT, Foss S, Kenanova VE, Olafsen T, Leikfoss IS, Roopenian DC, Wu AM, Sandlie I. Andersen JT, et al. Among authors: kenanova ve. J Biol Chem. 2012 Jun 29;287(27):22927-37. doi: 10.1074/jbc.M112.355131. Epub 2012 May 8. J Biol Chem. 2012. PMID: 22570488 Free PMC article.

10

Tailoring antibodies for radionuclide delivery.

Kenanova V, Wu AM. Kenanova V, et al. Expert Opin Drug Deliv. 2006 Jan;3(1):53-70. doi: 10.1517/17425247.3.1.53. Expert Opin Drug Deliv. 2006. PMID: 16370940 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page